In patients that are on ACEIs/ARBs before infection with SARS-CoV‐2, ACEI/ARB-mediated upregulation of ACE2 in airway epithelium could increase the risk of becoming infected with SARS-CoV‐2 and may facilitate initial virus propagation/spread. This evidence concerns the gene ACE2 and infection.